Ocular Therapeutix Inc

NASDAQ:OCUL  
18.40
+0.29 (+1.60%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.40B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$9.91 Million
Adjusted EPS-$0.17
See more estimates
10-Day MA$18.58
50-Day MA$19.94
200-Day MA$12.47
See more pivots

Ocular Therapeutix, Inc. Stock, NASDAQ:OCUL

15 Crosby Drive, 24 Crosby Drive, Bedford, Massachusetts 01730
United States of America
Phone: +1.781.357.4000
Number of Employees: 161

Description

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.